|
 |
EplerenoneThis page contains recent news articles, when available, and an overview of Eplerenone but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Eplerenone (when available) Eplerenone, an aldosterone receptor antagonist similar to spironolactone, has been shown to produce sustained increases in plasma renin and serum aldosterone, consistent with inhibition of the negative regulatory feedback of aldosterone on renin secretion. The resulting increased plasma renin activity and aldosterone circulating levels do not overcome the effects of eplerenone. Eplerenone selectively binds to recombinant human mineralocorticoid receptors relative to its binding to recombinant human glucocorticoid, progesterone and androgen receptors. For improvement of survival of stable patients with left ventricular systolic dysfunction (ejection fraction <40%) and clinical evidence of congestive heart failure after an acute myocardial infarction. Mechanism Of Action: Eplerenone binds to the mineralocorticoid receptor and thereby blocks the binding of aldosterone (component of the renin-angiotensin-aldosterone-system, or RAAS). Aldosterone synthesis, which occurs primarily in the adrenal gland, is modulated by multiple factors, including angiotensin II and non-RAAS mediators such as adrenocorticotropic hormone (ACTH) and potassium. Aldosterone binds to mineralocorticoid receptors in both epithelial (e.g., kidney) and nonepithelial (e.g., heart, blood vessels, and brain) tissues and increases blood pressure through induction of sodium reabsorption and possibly other mechanisms. News Articles on Eplerenone November 2009 Mayo Clinic Health Letter Highlights Self-Care Tips for ... - Nov 13, 2009 Aldosterone antagonists: This category, which includes spironolactone and eplerenone, removes sodium and water from the bloodstream. ... PR Newswire (press release) HEALTH CARE AND BLOOD PRESSURE - Nov 11, 2009 Your doctor may also suggest nonthiazide diuretic drugs, such as spironolactone (Aldactone) or eplerenone (Inspra), which change the way your body absorbs ... The Cypress Times Aldosterone Antagonists Recommended but Rarely Used - Oct 20, 2009 That side effect can be avoided by using other drugs in the class, although the alternatives are branded drugs such as eplerenone (Inspra), Bhatt said. ... MedPage Today Is eplerenone a cost-effective therapy for heart failure patients... - May 12, 2005 Weintraub WS et al. (2005) Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular ... Nature.com Eplerenone | Life and style | BMJ Group - Jul 25, 2008 Probably. If you've had a heart attack and have a particular kind of heart failure, taking eplerenone together with other drugs might help you live longer. ... guardian.co.uk Does eplerenone benefit postinfarction patients with heart failure... - Aug 23, 2005 Pitt B et al. for the EPHESUS Investigators (2005) Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in ... Nature.com Adding spironolactone to conventional antihypertensives reduces … - Dec 29, 2005 Recently, my research group found that low-dose eplerenone did not ... Is the restrictive label for eplerenone a barrier to its use in diabetic patients? ... Nature.com Cardiovascular Research; Eplerenone cardioprotective mechanisms may … - May 17, 2006 To elucidate the beneficial cardioprotective mechanism of eplerenone, ... "Eplerenone administration resulted in significant improvement of cardiac function ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Eplerenone (Systemic). - Oct 27, 2005 Eplerenone ep-LAYR-eh-nown belongs to the general class of medicines called antihypertensives. It is used to treat high blood pressure (hypertension). ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com … Aldosterone-Receptor Antagonist Eplerenone in Asymptomatic... - Sep 12, 2008 Study Question: Does the selective aldosterone-receptor antagonist eplerenone delay the onset of left ventricular (LV) systolic dysfunction or reduce LV ... Cardiosource Eplerenone after AMI complicated by heart failure: the earlier, the... - Apr 1, 2007 Eplerenone after AMI complicated by heart failure: the earlier, the better. Early initiation of eplerenone after acute MI (AMI) complicated by heart failure ... $9.94 - Formulary - Alacra Store Eplerenone Therapy for Patients with HF and LVD for AMI: Synopsis - Dec 13, 2005 The risk of early in-hospital mortality after an acute myocardial infarction (AMI) is raised significantly if the patient has left ventricular systolic ... Medscape Implant Device Effectively Maintains Heart Function For Transplant... - Apr 1, 2007 The results demonstrate that eplerenone did not have an additional effect ... "Our findings suggest eplerenone does not effect remodeling (a surrogate for ... Medical News Today - Medical News Today (press release) Implant device effectively maintains heart function for transplant... - Mar 27, 2007 The results demonstrate that eplerenone did not have an additional effect ... "Our findings suggest eplerenone does not effect remodeling (a surrogate for ... eurekalert.org Mineralocorticoid-receptor blockade, hypertension and heart failure - May 24, 2005 EPHESUS 2 addressed the use of eplerenone in heart failure after ... The outcomes were again distinct (use of eplerenone led to a reduction of 15% in ... Nature.com … , Clayton; Binding determinants of eplerenone and spironolactone are - Feb 9, 2005 FM Rogerson and colleagues of Prince Henry's Institute of Medical Research in Australia continued, "Eplerenone has a very low affinity for the ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Fresh Approach To Diet And Medication Improves Recovery After Heart … - Mar 29, 2007 How Early Should Eplerenone Be Initiated in Acute Myocardial Infarction ... "Attending physicians tend to delay prescribing eplerenone until after the ... sciencedaily.com … Receptor; Binding determinants of eplerenone and spironolactone... - Feb 7, 2005 2005 FEB 7 - (NewsRx.com & NewsRx.net) -- Researchers have investigated differences in the determinants of eplerenone, spironolactone and aldosterone ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones Fresh approach to diet and medication improves recovery after heart … - Mar 25, 2007 How Early Should Eplerenone Be Initiated in Acute Myocardial Infarction ... "Attending physicians tend to delay prescribing eplerenone until after the ... eurekalert.org Hypertension; Eplerenone is an effective, well-tolerated antihypertens... - Feb 28, 2005 2005 FEB 28 - (NewsRx.com & NewsRx.net) -- Eplerenone in hypertension was the focus of a recent report. According to the report from Canada, ... Pay-Per-View - Cardiovascular Week - Factiva, from Dow Jones University of Calgary; Eplerenone is an effective, well-tolerated … - Mar 2, 2005 2005 MAR 2 - (NewsRx.com & NewsRx.net) -- Eplerenone in hypertension was the focus of a recent report. According to the report from Canada, "Appreciation of ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Hypertension; Eplerenone is an effective, well-tolerated antihypertens... - Mar 5, 2005 2005 MAR 5 - (NewsRx.com & NewsRx.net) -- Eplerenone in hypertension was the focus of a recent report. According to the report from Canada, "Appreciation of ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones … Early Use of Pfizer's Inspra(R) (Eplerenone) Significantly Reduced... - Aug 8, 2005 REVISED: Early Use of Pfizer's Inspra(R) (Eplerenone) Significantly Reduced Death Rates Among Heart Attack Patients With Reduced Heart Muscle Function and ... Pay-Per-View - PR Newswire Europe - HighBeam Research … Early Use of Pfizer's Inspra(R) (Eplerenone) Significantly Reduced... - Aug 8, 2005 Early Use of Pfizer's Inspra(R) (Eplerenone) Significantly Reduced Death Rates Among Heart Attack Patients With Reduced Heart Muscle Function and Signs of ... Pay-Per-View - PR Newswire Europe - HighBeam Research Figure 4 : Modification of mineralocorticoid receptor function by... - Nov 23, 2008 ...(d) Electron micrographs of glomeruli showing protected foot process structure in eplerenone-treated Arhgdia -/- mice. Scale bar, 1 m. ... Nature.com eplerenone Pfizer marketed, Netherlands (heart failure).(Pharmaceutica... - Mar 14, 2005 In November 2004 Pfizer launched eplerenone (INSPRA), ... eplerenone, epoxymexrenone, CGP 30083, SC 66110, INSPRA, C1D, Coronary Therapy, C2A, ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Hormone aldosterone is promising target for stroke treatment - Nov 30, 2005 Last year, a more-specific second generation of the drug, eplerenone, received Food and Drug Adminstration approval. Still neither version has become a ... PsychCentral.com Ann Intern Med -- Rapid Responses for Al-Khatib et al., 142 (8) 593... - May 3, 2005 These differences make comparisons between eplerenone and ICD therapy difficult. ... Eplerenone, a selective aldosterone blocker, in patients with left ... Annals of Internal Medicine Implications of the Multicenter Automatic Defibrillator Implantation... - Jan 3, 2006 Dr. Weintraub argues that eplerenone, an aldosterone blocker, ... These differences make comparisons between eplerenone and ICD therapy difficult (1, 2). ... Annals of Internal Medicine Heart Failure: New chapter opens in story of post-MI therapy - Jul 23, 2005 The study results show that eplerenone reduced all-cause mortality by 31% (p=0.004) ... Initiation of eplerenone within 30 days of the infarct maximises the ... Medical News Today - Medical News Today (press release) Heart Failure: New chapter opens in story of post-MI therapy - Jul 25, 2005 In the light of these findings, the study authors conclude that for these patients: “It would appear prudent to initiate eplerenone as early as possible ... i-newswire.com New treatments and interventions for chronically impaired cardiac … - Mar 30, 2007 The results demonstrate that eplerenone did not have an additional effect ... "Our findings suggest eplerenone does not effect remodeling (a surrogate for ... News-Medical.net Aldosterone antagonists treat tough HT.(Hypertension)(Disease/Disorder... - Jul 15, 2006 ..."Treatment with either eplerenone or spirolactone leads to a substantial reduction ... He is a consultant to Pfizer Inc., which markets eplerenone (Inspra). ... Free with registration - Family Practice News - AccessMyLibrary.com Change in the pattern of adrenal venous sampling over time in... - Aug 28, 2008 Subsequently, he was treated with eplerenone for low renin hypertension. ... Two years later, he developed sexual dysfunction and eplerenone was replaced by ... Nature.com Is abiraterone acetate well tolerated and effective in the treatment... - Aug 8, 2008 ...tolerated but often induced a syndrome of secondary mineralocorticoid excess that improved with eplerenone (a mineralocorticoid receptor antagonist). ... Nature.com Aldosterone antagonists treat tough HT.(Hypertension)(Disease/Disorder... - Jul 15, 2006 ..."Treatment with either eplerenone or spirolactone leads to a substantial reduction ... He is a consultant to Pfizer Inc., which markets eplerenone (Inspra). ... Pay-Per-View - Family Practice News - HighBeam Research Inspra non ritarda la disfunzione ventricolare sinistra nella stenosi... - Nov 27, 2008 I pazienti sono stati assegnati in modo casuale ad Eplerenone 100 mg/die ( n=33 ) ... Risultati simili tra gruppo Eplerenone e placebo sono stati osservati ... XagenaSalute Aldosterone Blockade in Heart Failure - Jan 30, 2006 The aldosterone receptor antagonists spironolactone and eplerenone can improve ... Eplerenone, a selective aldosterone blocker, in patients with left ... Medscape Does Aldosterone-to-Renin Ratio Predict the Antihypertensive Effect... - Feb 10, 2005 More recently this issue has been explored with the newer specific aldosterone antagonist, eplerenone. Flack et al 13 compared the efficacy and tolerability ... Nature.com Current Guidelines for Treatment of Heart Failure: 2006 Update - May 11, 2007 The aldosterone antagonists, spironolactone and eplerenone, ... Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction ... Medscape Primary Hyperaldosteronism Associated With Hypertensive Emergencies - Jun 7, 2005 He was treated with a multidrug regimen including 100 mg/d of eplerenone, ... The patient was subsequently started on 50 mg/d of eplerenone plus 10 mg/d of ... Nature.com Progestins and Potassium - Jan 24, 2005 Then, in Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and ... Eplerenone, a selective aldosterone blocker, in patients with left ... Nature.com Article: New Drug Helps Heart Failure Symptoms - AP Online | HighBeam... - Mar 25, 2007 Eplerenone ... aldosterone, which has been implicated in heart failure. Another drug, spironolactone, also ... The Hindustan Times ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Diagnosis of adenomatous primary aldosteronism in a patient with... - Jun 15, 2005 Eplerenone, a newly available, selective aldosterone-receptor blocker with good ... (2002) Efficacy of eplerenone added to renin–angiotensin blockade in ... Nature.com A Publication of BMJ Publishing Group - Aug 1, 2006 Eplerenone (in Persons Receiving Medical Treatment for Myocardial Infarction Complicated by Left Ventricular Dysfunction and Heart Failure). ... AAFP News Now Diagnosis of primary aldosteronism in a patient with an incidentally... - Feb 16, 2007 Aldosterone receptor antagonists, including spironolactone and eplerenone, and high-dose amiloride therapy, should be discontinued 6 weeks before testing. ... Nature.com New guidelines released for primary aldosteronism - Sep 8, 2008 The mineralocorticoid receptor antagonist of choice is spironolactone; eplerenone may be used as an alternative for those patients intolerant of ... Endocrine Today Pediatric Hypertension: Does It Have an Impact on Cognition? - Jul 17, 2008 Efficacy and safety of eplerenone in hypertensive children: a randomized, double-blind study. J Clin Hypertens. 2008;10(5 suppl A):A152-A153. ... Medscape Aldosterone, Normotension, and Diastolic Dysfunction - Jul 19, 2005 The combination of eplerenone and the angiotensin-converting enzyme inhibitor Enalapril ... Finally, in dose titration studies of eplerenone in essential ... Journal of Clinical Endocrinology and... Drug dosing adjustments in patients with chronic kidney disease.(Drug... - May 15, 2007 Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction [Published correction appears in N ... $4.95 - American Family Physician - ECNext Factiva Search - May 15, 2006 Dokkyo University, Mibu; Eplerenone cardioprotective mechanisms may be partly ... 2006 MAY 15 - (NewsRx.com) -- Eplerenone administration resulted in ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Article: Leaders urge improved care for Black heart patients - New … - Jun 28, 2006 Eplerenone is an ... pressure was found among Black patients taking eplerenone ... New Pittsburgh Courier. Article: Healthy Living: A disease you can live ... Pay-Per-View - New Pittsburgh Courier - HighBeam Research Press Release: New Benefit Shown for Patients With Damaged Hearts. - ... - Jul 26, 2005 Results from the study show that eplerenone reduced death rate from all causes in ... Article: Early Use of Pfizer's Inspra(R) (Eplerenone) Significantly . ... Pay-Per-View - PR Newswire Europe - HighBeam Research What Next for Patients With Resistant Hypertension? - Oct 1, 2005 Limited experience with a newer aldosterone antagonist, eplerenone, ... Efficacy and tolerability of eplerenone and losartan in hypertensive black and white ... $4.95 - Consultant - ECNext Heart Failure; Aldosterone blocker recommended for patients with... - Jun 24, 2005 The new guidelines are based in part on the landmark Eplerenone post acute ... In Europe, INSPRA (eplerenone) is indicated, in addition to standard therapy ... Pay-Per-View - Genomics & Genetics Weekly - Factiva, from Dow Jones More generics receive clearance for marketing by the FDA. - Dec 8, 2008 Sandoz has also announced the introduction of eplerenone tablets, ... Eplerenone tablets are used to treat high blood pressure as well as heart failure. ... $9.94 - Chain Drug Review - Alacra Store How to Optimize Aldosterone Blockade - Apr 24, 2007 Urinary albumin excretion de-creased by 62% in the eplerenone group, 45% in the enalapril group, and 74% in the two-drug group. The proportion of patients ... Renal and Urology News Pharmacy Update - Case studies: heart failure.(Case study) - Dec 15, 2007 A similar monitoring schedule is advisable for eplerenone. Urea, creatinine and electrolytes should be monitored after starting diuretics at similar ... $4.95 - Chemist & Druggist - ECNext Japanese regulator gives nod to three new drugs. - May 21, 2007 Eplerenone, a selective aldosterone receptor antagonist from world drug giant Pfizer, has been approved in the USA under the brand name of Inspra. ... $9.94 - Pharma Marketletter - Alacra Store Hormone Aldosterone Is Promising Target For Stroke Treatment - Dec 5, 2005 Last year, a more-specific second generation of the drug, eplerenone, received Food and Drug Adminstration approval. Still neither version has become a ... Medical News Today - Medical News Today (press release) Heart Failure After Myocardial Infarction: A Neglected Problem? - Jun 30, 2005 Pitt B, Remme W, Zannad F et al., for the Eplerenone Post-Acute Myocardial Infarction ... Eplerenone, a selective aldosterone blocker, in patients with left ... Medscape Ischemic Cardiomyopathy - Symptoms, Diagnosis, Treatment of Ischemic ... - Sep 3, 2008 ...lisinopril), beta-blockers (metoprolol, carvedilol), and diuretics such as furosemide (Lasix), spironolactone, and eplerenone. ... New York Times Article: Clinical question: Does cardiac rehabilitation improve... - Dec 1, 2006 Eplerenone Cleared for CHF Patients with Sustained MI The FDA has approved Pfizer ... congestive heart failure (CHF) in patients who have sustained a ... Pay-Per-View - Physical Therapy - HighBeam Research Factiva Search - Feb 8, 2005 Mineralocorticoid Receptor; Binding determinants of eplerenone and spironolactone are similar to each other. 08 February, 2005 Science Letter ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Factiva Search - Mar 1, 2005 Hypertension; Eplerenone is an effective, well-tolerated antihypertensive agent ... 2005 MAR 1 - (NewsRx.com & NewsRx.net) -- Eplerenone in hypertension was ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Factiva Search - Feb 28, 2005 Hypertension; Eplerenone is an effective, well-tolerated antihypertensive agent ... 2005 FEB 28 - (NewsRx.com & NewsRx.net) -- Eplerenone in hypertension ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones Factiva Search - Feb 7, 2005 Mineralocorticoid Receptor; Binding determinants of eplerenone and spironolactone are similar to each other. 07 February, 2005 ... Pay-Per-View - Pain & Central Nervous System Week - Factiva, from Dow Jones Advances in the treatment of heart failure. - Oct 1, 2005 Eplerenone (Inspra), first approved by the FDA in 2002 for high blood pressure, is an alternative that seems to cause fewer side effects. ... $4.95 - Harvard Health Letter - ECNext Factiva Search - Feb 21, 2005 ...eplerenone Pfizer marketed, Denmark (heart failure).(Brief Article) ... In November 2004, Pfizer launched eplerenone (INSPRA), its selective aldosterone ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Factiva Search - Mar 1, 2005 Hypertension; Eplerenone is an effective, well-tolerated antihypertensive agent ... 2005 MAR 1 - (NewsRx.com & NewsRx.net) -- Eplerenone in hypertension was ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Press Release: New ESC Heart Failure Guidelines Recommend Addition … - May 24, 2005 Pfizer's INSPRA(R) (eplerenone) has the potential to save more lives. New chronic heart failure guidelines issued by the European Society of Cardiology ... Pay-Per-View - PR Newswire Europe - HighBeam Research Urinary Aldosterone-to-active-renin Ratio: A Useful Tool for Predictin... - Dec 18, 2007 In aldosterone-treated rats on a high–salt diet, the selective antialdosterone, eplerenone, reversed the increase in arterial stiffness and cardiac fibrosis ... Nature.com Press Release: Head-to-Head Study Showed Prasugrel Statistically … - Aug 21, 2008 Article: Early Use of Pfizer's Inspra(R) (Eplerenone) Significantly ... PR Newswire Europe; August 8, 2005 ; 700+ words ... ... initial treatment, ... Pay-Per-View - PR Newswire Europe - HighBeam Research Could renin inhibition be the next step forward in the treatment of... - Jul 22, 2008 Aldosterone inhibition (with spironolactone or eplerenone) has also been combined with the use of ACE inhibitors or ARBs for DKD. ... Nature.com ë°”ì†ŒíŽ©í‹°ë‹¤ì œ ì–µì œì œ, ê°•ì•• 우수 불구 혈관부종 - Oct 31, 2005 ...ë”°ë?¼ì„œ aldosterone antagonist(spironolactone, eplerenone) 는 í˜ˆì••ì¡°ì ˆ, ... Eplerenoneì?€ spironolactoneì—? 비해 mineralocorticoid receptorì—? 대한 길í•ëŠ¥ë ¥ì?€ ... bosa.co.kr Eplerenon bei Herzinsuffizienz nach akutem Myokardinfarkt auch … - Apr 26, 2005 Eplerenone, a selective aldosterone blocker, in patients with left ventricular ... Cost-effectiveness of Eplerenone compared with placebo in patients with ... journalmed.de Dilated cardiomyopathy - Sep 18, 2007 These drugs include spironolactone (Aldactone) and eplerenone (Inspra). They are primarily potassium-sparing diuretics, but they have additional properties ... CNN International Best Treatments: Managing Heart Failure.(Cover Story) - Oct 3, 2005 An old drug called spironolactone and a newer one called eplerenone can lower mortality for patients with severe heart failure, but they can also cause ... Free with registration - Newsweek - AccessMyLibrary.com Advances in cardiovascular medicine - Jun 6, 2005 A newer agent, eplerenone, has recently been found to significantly reduce mortality ... Eplerenone, a selective aldosterone blocker, in patients with left ... Pay-Per-View - The Practitioner - Factiva, from Dow Jones High blood pressure (hypertension) - Aug 7, 2008 Your doctor may also suggest nonthiazide diuretic drugs, such as spironolactone (Aldactone) or eplerenone (Inspra), which change the way your body absorbs ... CNN International Article: P back in the loop after S bend?(ecycling of human urine)(Bri... - Aug 1, 2007 Article: SPE-LC-MS/MS assay for Eplerenone and metabolite in human . ... Eplerenone, and its hydrolyzed metabolite in human urine was validated in a recent ... Pay-Per-View - Ecos - HighBeam Research Article: FINDINGS - The Washington Post | HighBeam Research - FREE … - Aug 30, 2005 Article: Early Use of Pfizer's Inspra(R) (Eplerenone) Significantly ... PR Newswire Europe; August 8, 2005 ; 700+ words . ... Pay-Per-View - Washington Post - HighBeam Research PATENTS - Mar 21, 2005 6863902--Immediate release eplerenone compositions, G.D. Searle & Co., Skokie. 6863980--Monolithic composite firewall, Boeing Co., Chicago ... Pay-Per-View - Chicago Tribune - ProQuest Archiver Palm Beach Post: Palm Beach & Treasure Coast news, sports, … - Jul 17, 2006 ...lisinopril), beta-blockers (metoprolol, carvedilol), and diuretics such as furosemide (Lasix), spironolactone, and eplerenone. ... Palm Beach Post A 65 year-old man with poorly controlled hypertension and chronic... - Aug 8, 2007 There is no reliable experience with the weaker mineralocorticoid antagonist, eplerenone, in primary aldosteronism and, in my opinion, this drug should be ... Nature.com Why Are So Many Pills Used To Treat Heart Failure? - May 24, 2008 These drugs, including spironolactone (Aldactone) and eplerenone (Inspra), are primarily potassium-sparing diuretics that may or may not be the part of the ... Pay-Per-View - Tampa Tribune - ProQuest Archiver Exelixis Turns X-Ceptor Into Partners: Third Deal Signed - Mar 21, 2006 There are two FDA-approved MR antagonists on the market for hypertension and congestive heart failure due to their vascular protective effects, eplerenone ... BioWorld Online - BioWorld Online Finance: Promotional Productivity - Mar 1, 2006 Look at Inspra (eplerenone). Pfizer launched this drug in Q4 2003 and continues to pump money into this problem child, despite anemic sales of roughly $40 ... PharmExec.com Article: Deaths plunge for heart attack patients - Chicago Sun-Times... - May 2, 2007 Article: Early Use of Pfizer's Inspra(R) (Eplerenone) Significantly ... PR Newswire Europe; August 8, 2005 ; 700+ words ... ... compared to heart attack ... Pay-Per-View - Chicago Sun-Times - HighBeam Research Article: Debate renewed: diabetes drug ups heart risk.(This Week)( … - Sep 15, 2007 Article: Early Use of Pfizer's Inspra(R) (Eplerenone) Significantly ... PR Newswire Europe; August 8, 2005 ; 700+ words ... ... Cardiology (JACC). ... Pay-Per-View - Science News - HighBeam Research Article: NHL cancels meeting with board of governors - Deseret News (... - Jan 7, 2005 ...days of HF hospitalizations compared to placebo ... effects of eplerenone on length of stay and total days of heart failure hospitalization after ... ... Pay-Per-View - Deseret News - HighBeam Research Aldosterone receptor antagonism: mechanisms and targets - Sep 3, 2006 ...independent of mineralocorticoid receptors (MR; insensitive to antagonists spironolactone and eplerenone), which leaves the door open for new therapies. ... European Society of Cardiology Independent Nurse: Clinical - Top 50 - Acute MI. - Jan 27, 2006 Eplerenone improves outcome in patients with heart failure after acute MI; as it is expensive, spironolactone is more often used. ... Free with registration - GP - AccessMyLibrary.com 辉瑞制è?¯å…¬å?¸å¼ºåŒ–在日本的开å?‘ - Mar 21, 2005 ...抗霉è?Œæ„ŸæŸ“çš„è?¯ç‰©Prodif(fosfluconazole)。2005å¹´å?¯èƒ½åœ¨æ—¥æœ¬èŽ·å¾—批准的产å“?有全身 性抗真è?Œè?¯ç‰©Vfend(voriconazole)，Inspra(eplerenone)以å?ŠDetrol(tolterodine)。 ... ä¸é‡‘在线 SrÄ?no popuÅ¡Ä?anje postaja eden izmed vodilnih vzrokov za smrt - Aug 8, 2007 »Kot sem že omenila, so zdravilo spironolakton preizkuÅ¡ali pri zelo hudih bolnikih, v novi Å¡tudiji Ephesus (Eplerenone Post-Acute Myocardial Infarction ... Dnevnik/si Guidelines on Management of Primary Aldosteronism Issued - Aug 29, 2008 Spironolactone is suggested as the primary agent, with eplerenone as an alternative. Use of the lowest dose of glucocorticoid that can normalize blood ... Medscape Torcetrapib-induced Blood Pressure Elevation Is Independent of CETP … - Nov 5, 2007 On the other hand, the blood pressure increase with torcetrapib was not blocked by the aldosterone antagonist eplerenone. ... Cardiosource The Failure of Torcetrapib -- The Search for the Reason Why: Supportin... - Dec 11, 2007 5 mg/kg administered over 30 minutes was not reduced in rats that had been treated with 30 mg/kg of eplerenone, a mineralocorticoid receptor antagonist. ... Medscape Australia OKs Inspra.(Inspra of Pfizer Inc. enters into Australia's … - Dec 19, 2005 Pfizer's Inspra (eplerenone) is to be added to Australia's Pharmaceutical Benefits Scheme from February 1, 2006. The government estimates that, ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Health Status Questionnaire Recommended for Heart Failure … - Apr 12, 2007 Dr. Spertus and the other investigators observed 1358 patients participating in the international Eplerenone Neurohormonal Efficacy and Survival Study ... Medscape Independent Nurse: Clinical - Prescribing for heart failure. - Jul 9, 2007 Eplerenone is a new aldosterone antagonist that does not cause gynaecomastia, but requires similar monitoring to aldosterone. ... Free with registration - GP - AccessMyLibrary.com Aldosterone Blockade and Left Ventricular Dysfunction: A Systematic … - Dec 23, 2008 Study Question: What is the evidence on the efficacy of spironolactone (SP), eplerenone (EP), or canrenoate (CAN) in left ventricular systolic dysfunction? ... Cardiosource Mayo Clinic expertise - Jan 3, 2008 These drugs include spironolactone (Aldactone) and eplerenone (Inspra). They're primarily potassium-sparing diuretics, but they have additional properties ... MayoClinic.com Brand Names/Synonyms: Eplerenone is also known by the following brand names and/or synonymsCgp 30083; Eplerenone; Eplerenone [Usan]; Epoxymexrenone; INSPRA; Inspra; SC-66110 Drug Category: Eplerenone is categorized under the following by the FDA: Antihypertensive Agents; ATC:C03DA04 Dosage Forms: TABLET (film-coated - 25, 50 mg) Absorption: The absolute bioavailability of eplerenone is unknown. Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: Not Available |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |